Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.

J Invest Dermatol

Molecular Signaling and Cell Death Unit, Inflammation Research Center (IRC), VIB, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. Electronic address:

Published: June 2018

In humans, receptor-interacting protein kinase 4 (RIPK4) mutations can lead to the autosomal recessive Bartsocas-Papas and popliteal pterygium syndromes, which are characterized by severe skin defects, pterygia, as well as clefting. We show here that the epithelial fusions observed in RIPK4 full knockout (KO) mice are E-cadherin dependent, as keratinocyte-specific deletion of E-cadherin in RIPK4 full KO mice rescued the tail-to-body fusion and fusion of oral epithelia. To elucidate RIPK4 function in epidermal differentiation and development, we generated epidermis-specific RIPK4 KO mice (RIPK4). In contrast to RIPK4 full KO epidermis, RIPK4 epidermis was normally stratified and the outside-in skin barrier in RIPK4 mice was largely intact at the trunk, in contrast to the skin covering the head and the outer end of the extremities. However, RIPK4 mice die shortly after birth due to excessive water loss because of loss of tight junction protein claudin-1 localization at the cell membrane, which results in tight junction leakiness. In contrast, mice with keratinocyte-specific RIPK4 deletion during adult life remain viable. Furthermore, our data indicate that epidermis-specific deletion of RIPK4 results in delayed keratinization and stratum corneum maturation and altered lipid organization and is thus indispensable during embryonic development for the formation of a functional inside-out epidermal barrier.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.12.031DOI Listing

Publication Analysis

Top Keywords

ripk4
13
ripk4 full
12
ripk4 mice
12
skin barrier
8
tight junction
8
mice
6
keratinocyte-specific ablation
4
ablation ripk4
4
ripk4 allows
4
allows epidermal
4

Similar Publications

Plasma genome-wide mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis.

Respir Res

October 2024

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277#, Yanta West Road, Xi'an, Shaanxi Province, 710061, China.

Background: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease with a very poor prognosis. Existing drugs for the treatment of IPF are still insufficient. Therefore, there is still a need to explore new drug targets for preventing and treating IPF.

View Article and Find Full Text PDF

RIPK4 promotes oxidative stress and ferroptotic death through the downregulation of ACSM1.

Proc Natl Acad Sci U S A

October 2024

Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

One of the most critical axes for cell fate determination is how cells respond to excessive reactive oxygen species (ROS)-oxidative stress. Extensive lipid peroxidation commits cells to death via a distinct cell death paradigm termed ferroptosis. However, the molecular mechanism regulating cellular fates to distinct ROS remains incompletely understood.

View Article and Find Full Text PDF
Article Synopsis
  • * The study utilized genetic data to analyze over 2600 druggable genes, identifying 16 genes linked to improved functional outcomes, with further support from analysis techniques like Mendelian randomization and colocalization.
  • * Four key candidate genes were pinpointed as potential therapeutic targets to enhance recovery after ischemic stroke, although more research is needed to understand their mechanisms and ensure safety.
View Article and Find Full Text PDF
Article Synopsis
  • Somatic copy number alterations (SCNAs), especially arm-level SCNAs, are linked to cancer growth and resistance to treatment, but their role in triple-negative breast cancer (TNBC) is not well understood.
  • In this study, researchers found that certain arm-level SCNAs, like gains at 21q and 7p, are connected to poorer survival rates in TNBC patients, with the gene RIPK4 on 21q being particularly significant.
  • Targeting RIPK4 in experiments showed promise, as it reduced tumor growth and improved survival by enhancing immune cell infiltration, suggesting RIPK4 could be a key factor in TNBC progression and its ability to spread.
View Article and Find Full Text PDF

GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.

Oncogene

June 2024

Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, China.

Receptor-interacting protein kinase 4 (RIPK4) is increasingly recognized as a pivotal player in ovarian cancer, promoting tumorigenesis and disease progression. Despite its significance, the posttranslational modifications dictating RIPK4 stability in ovarian cancer remain largely uncharted. In this study, we first established that RIPK4 levels are markedly higher in metastatic than in primary ovarian cancer tissues through single-cell sequencing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!